Amiodarone is one of the most commonly prescribed antiarrhythmic agents. It can treat a
wide range of arrhythmia, including both ventricular and supraventricular tachycardia, and …

Background Amiodarone is a highly effective treatment for supraventricular and ventricular
tachyarrhythmia; however, it could be associated with several serious adverse effects …

Objectives Amiodarone is widely used to treat arrhythmia. However, amiodarone is known
for its severe toxicity to the liver, lungs, and thyroid. Amiodarone causes liver damage …

Amiodarone is a class III antiarrhythmic agent that inhibits adrenergic stimulation by blocking
alpha and beta receptors. It prolongs action potential and refractory period in myocardial …

Hepatotoxicity caused by chronic oral amiodarone is well documented with around 15-20%
incidence rate. However, acute liver failure due to intravenous (IV) amiodarone is rare …

Hepatotoxicity caused by chronic oral amiodarone is well documented with around 15-20%
incidence rate. However, acute liver failure due to intravenous (IV) amiodarone is rare …

Amiodarone is a highly effective treatment for life-threatening supraventricular and
ventricular arrhythmias, namely in the setting of acutely decompensated heart failure …

Amiodarone is a lipophilic structure with a half-life of 25–100 days. Long-term oral
amiodarone is associated with photosensitivity, thyroid dysfunction, and pulmonary and …

Although amiodarone is a widely used and effective long-term antiarrhythmic drug, it is
known to have life-threatening adverse effects, including acute hepatotoxicity. Although the …

Amiodarone, a class III antiarrhythmic drug, is commonly used for the management of life-
threatening ventricular arrhythmias, atrial fibrillation, and other refractory supra-ventricular …